Cargando…
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis
Idiopathic pulmonary fibrosis is a chronic, progressive, and lethal lung disease of unknown etiology. Antifibrotic drugs, including pirfenidone, are currently used for the treatment of the disease. The oral administration of pirfenidone is an effective therapy, as demonstrated by several clinical tr...
Autores principales: | Okano, Tomohito, Kobayashi, Tetsu, Yasuma, Taro, D’Alessandro-Gabazza, Corina N., Toda, Masaaki, Fujimoto, Hajime, Nakahara, Hiroki, Okano, Yuko, Takeshita, Atsuro, Nishihama, Kota, Saiki, Haruko, Tomaru, Atsushi, Fridman D’Alessandro, Valeria, Ishida, Satoru, Sugimoto, Hiromi, Takei, Yoshiyuki, Gabazza, Esteban C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774321/ https://www.ncbi.nlm.nih.gov/pubmed/33390975 http://dx.doi.org/10.3389/fphar.2020.593620 |
Ejemplares similares
-
Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
por: Inoue, Ryo, et al.
Publicado: (2023) -
Protein S is Protective in Acute Lung Injury by Inhibiting Cell Apoptosis
por: Baffour Tonto, Prince, et al.
Publicado: (2019) -
Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
por: Okano, Yuko, et al.
Publicado: (2021) -
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
por: Fujiwara, Takumi, et al.
Publicado: (2020) -
Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions
por: D’Alessandro, Valeria Fridman, et al.
Publicado: (2022)